Max Dale Cooper | |
---|---|
Born | Max Dale Cooper [1] August 28, 1933 [2] |
Nationality | American |
Alma mater | Tulane University University of Mississippi Holmes Junior College |
Known for | T cell and B cell biology |
Spouse | Rosalie Cooper |
Awards | Albert Lasker Award for Basic Medical Research Japan Prize Robert Koch Award Sandoz Prize for Immunology |
Scientific career | |
Institutions | Emory University University of Alabama at Birmingham Howard Hughes Medical Institute University of Minnesota University of California, San Francisco Hospital for Sick Children, London |
Max Dale Cooper ForMemRS (born August 31, 1933), is an American immunologist and a professor at the Department of Pathology and Laboratory Medicine and the Emory Vaccine Center of Emory University School of Medicine. [4] He is known for characterizing T cells and B cells. [5]
Cooper was born and raised in rural Mississippi. His father was the Superintendent of Education of a 12-grade school in Bentonia and his mother a teacher. [2] He lived with his family on the campus. [6] He was interested in becoming a physician at a young age, and his father, who wanted to study medicine but could not due to financial reasons, encouraged him to do so. [7] Cooper went to Holmes Junior College (now Holmes Community College) [8] on an American football scholarship from 1951 to 1952, [7] [9] then entered the University of Mississippi for pre-medical studies. [10]
In 1954, Cooper started studying medicine at the University of Mississippi School of Medicine. Since the school at that time was a two-year medical school and was becoming a four-year one, Cooper was offered the option of staying or transferring elsewhere. He chose to move to the Tulane University School of Medicine, [6] and obtained his MD in 1957. [9]
After graduating from medical school, Cooper interned at a hospital in Saginaw, Michigan for a year, and then returned to Tulane University School of Medicine for a residency. [6] In 1960, Cooper went to Hospital for Sick Children, London as pre-registration house officer and then research assistant until 1961. [6] From 1961 to 1962, he was a pediatric allergy and immunology fellow at the University of California, San Francisco. [9]
Cooper briefly returned to Tulane as an instructor, then moved to the Department of Pediatrics at the University of Minnesota in 1963 to as a medical fellow and instructor, working with Robert A. Good and conducting research. He became an assistant professor in 1966.
One year later he joined the University of Alabama at Birmingham (UAB) as a professor at the Division of Immunology and Allergy of the Department of Pediatrics and an associate professor at the Department of Microbiology. Over the next few years, Cooper also became a professor at the Department of Microbiology, of Pathology and of Medicine. [9] During this period, he was also involved with the Comprehensive Cancer Center (since 1971), the Multipurpose Arthritis Center (since 1979), and the Cystic Fibrosis Research Center (since 1981), all at UAB, [9] and was an investigator at the Howard Hughes Medical Institute between 1988 and 2006. [11]
In 2008, convinced by the Georgia Research Alliance, [12] where Emory University is a partner institution, Cooper moved to the Department of Pathology and Laboratory Medicine at the School of Medicine of Emory University in Georgia, US. [9] He is also a professor at the Winship Cancer Institute [13] and the Emory Vaccine Center, [14] and an Eminent Scholar at the Georgia Research Alliance. [12]
Cooper remains a Professor Emeritus of Medicine at UAB. [15]
Cooper was the president of the American Association of Immunologists between 1988 and 1989 and a member of their Council from 1983 to 1988. [16]
Cooper's research focus is the adaptive immune system, particularly T cells and B cells. Following Jacques Miller's discovery in 1961 of the immunological role of the thymus, [17] the scientific community believed that there is only one lineage of lymphocytes (the T cells), that produced by the thymus. As a pediatrician, Cooper was studying patients of the Wiskott–Aldrich syndrome, who have few lymphocytes but high levels of plasma cells and antibodies, which were thought to derive from T cells. [18]
Inspired by a report that the bursa of Fabricius (or the bursa) in chickens may be responsible for producing antibodies, [19] he conducted experiments in 1964 on chickens to determine the roles of the thymus and the bursa. [20] He removed the thymus or the bursa from chicks and irradiated them with X-ray to kill lymphocytes that may have been produced earlier by the thymus and bursa. [21]
The experiments showed irradiated chicks with the bursa removed did not have plasma cells, antibodies, and germinal centers, despite their intact thymus. Conversely, irradiated chickens with the thymus removed had low lymphocyte levels, but had normal antibodies, plasma cells, and germinal centers. [22] [23] The lymphocytes produced by the bursa are known as B cells. [24]
Again working on chickens, Cooper also made a contribution to deducing how B cells produce different types of antibodies at different stages of embryonic development, in the sequence of IgM, IgG, and IgA. [25] His experiments indicated a single lineage of B cells switch from IgM to producing other immunoglobulin isotypes, as opposed to multiple B cell subtypes each producing one immunoglobulin isotype. [26] This process is known as immunoglobulin class switching.
Collaborating with John Owen from the UK, Cooper used a series of experiments to determine the mammalian organ equivalent to the bursa and found that B cells are produced in the liver of fetal mice. [27] Together with independent reports by Pierre Vassalli [28] and Gustav Nossal [29] in 1974 that B cells were produced in the bone marrow of fetal mice, these discoveries show haematopoietic tissues generate B cells in mammals. [30]
More recently, Cooper studied the adaptive immune system in jawless vertebrates, including lampreys and hagfish. Working with Jan Klein, he confirmed these animals have cells functionally similar to mammalian T cells and B cells. [31] [32] Cooper's group also found that instead of antibodies, lampreys have a family of immune receptors. They named it variable lymphocyte receptor. [33] [34] Owing to the unique specificity of these antibody-counterparts and their distinction from human antibodies, they may be used in treating cancers such as multiple myeloma and brain cancer. [35] [36]
External videos | |
---|---|
Seminar by Max Cooper about immune cells in jawless vertebrates after an introduction about his career. |
In immunology, an antigen (Ag) is a molecule, moiety, foreign particulate matter, or an allergen, such as pollen, that can bind to a specific antibody or T-cell receptor. The presence of antigens in the body may trigger an immune response.
The immune system is a network of biological systems that protects an organism from diseases. It detects and responds to a wide variety of pathogens, from viruses to parasitic worms, as well as cancer cells and objects such as wood splinters, distinguishing them from the organism's own healthy tissue. Many species have two major subsystems of the immune system. The innate immune system provides a preconfigured response to broad groups of situations and stimuli. The adaptive immune system provides a tailored response to each stimulus by learning to recognize molecules it has previously encountered. Both use molecules and cells to perform their functions.
Immunology is a branch of biology and medicine that covers the study of immune systems in all organisms.
A lymphocyte is a type of white blood cell (leukocyte) in the immune system of most vertebrates. Lymphocytes include T cells, B cells, and Innate lymphoid cells (ILCs), of which natural killer cells are an important subtype. They are the main type of cell found in lymph, which prompted the name "lymphocyte". Lymphocytes make up between 18% and 42% of circulating white blood cells.
Niels Kaj Jerne, FRS was a Danish immunologist. He shared the Nobel Prize in Physiology or Medicine in 1984 with Georges J. F. Köhler and César Milstein "for theories concerning the specificity in development and control of the immune system and the discovery of the principle for production of monoclonal antibodies".
The adaptive immune system, also known as the acquired immune system, or specific immune system is a subsystem of the immune system that is composed of specialized, systemic cells and processes that eliminate pathogens or prevent their growth. The acquired immune system is one of the two main immunity strategies found in vertebrates.
In birds, the bursa of Fabricius is the site of hematopoiesis. It is a specialized organ that, as first demonstrated by Bruce Glick and later by Max Dale Cooper and Robert Good, is necessary for B cell development in birds. Mammals generally do not have an equivalent organ; the bone marrow is often the site of both hematopoiesis and B cell development. The bursa is present in the cloaca of birds and is named after Hieronymus Fabricius, who described it in 1621.
Jacques Francis Albert Pierre Miller AC FRS FAA is a French-Australian research scientist. He is known for having discovered the function of the thymus and for the identification, in mammalian species of the two major subsets of lymphocytes and their function.
In immunology, clonal selection theory explains the functions of cells of the immune system (lymphocytes) in response to specific antigens invading the body. The concept was introduced by Australian doctor Frank Macfarlane Burnet in 1957, in an attempt to explain the great diversity of antibodies formed during initiation of the immune response. The theory has become the widely accepted model for how the human immune system responds to infection and how certain types of B and T lymphocytes are selected for destruction of specific antigens.
Antonio Lanzavecchia is an Italian and Swiss immunologist. As a fellow of Collegio Borromeo he obtained a degree with honors in Medicine in 1976 from the University of Pavia where he specialized in Pediatrics and Infectious Diseases. He is Head Human Immunology Program, Istituto Nazionale di Genetica Molecolare-INGM, Milan and SVP Senior research Fellow, Humabs/Vir Biotechnology, Bellinzona and San Francisco (USA). Since 2017, he is also Professor at the Faculty of Biomedical Sciences of the Università della Svizzera italiana (USI).
Timothy "Tim" A. Springer is an immunologist and the Latham Family Professor at Harvard Medical School. He is also a professor at the Department of Biological Chemistry and Molecular Pharmacology and of the Division of Medical Sciences, and a Senior Investigator at the Research Program in Cellular and Molecular Medicine of the Boston Children's Hospital. Springer is best known for discovering the first integrins, LFA-1, and intercellular adhesion molecules (ICAMs), and for elucidating how these cell adhesion molecules function in the immune system. In recent years, Springer's research interest has expanded to malaria, transforming growth factor beta (TGF-β) signaling, and von Willebrand factor.
Betty Diamond is an American physician and researcher. She is director of the Institute of Molecular Medicine at Northwell Health's Feinstein Institute for Medical Research in Manhasset, NY. She was elected a member of the National Academy of Sciences in 2022.
Frederick W. Alt is an American geneticist. He is a member of the Immunology section of the National Academy of Sciences and a Charles A. Janeway Professor of Pediatrics, and Professor of Genetics at Harvard Medical School. He is the Director of the Program in Cellular and Molecular Medicine at the Boston Children's Hospital. He is a Howard Hughes Medical Institute investigator, since 1987.
James Patrick Allison is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas.
Harvey Cantor is an American immunologist known for his studies of the development and immunological function of T lymphocytes. Cantor is currently the Baruj Benacerraf Professor of Immunology and Microbiology at the Harvard Medical School.
J. (Joseph) Donald Capra is an American immunologist, physician-scientist, and was the 4th full-time president (1997–2007) and later, president emeritus, of the Oklahoma Medical Research Foundation (OMRF) in Oklahoma City, OK. While president, he helped to raise over $100 million and spearheaded major research growth in grants funded and faculty recruited to the institution.
Tasuku Honjo is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1). He is also known for his molecular identification of cytokines: IL-4 and IL-5, as well as the discovery of activation-induced cytidine deaminase (AID) that is essential for class switch recombination and somatic hypermutation.
Jawless vertebrates, which today consist entirely of lampreys and hagfish, have an adaptive immune system similar to that found in jawed vertebrates. The cells of the agnathan AIS have roles roughly equivalent to those of B-cells and T-cells, with three lymphocyte lineages identified so far:
Michel C. Nussenzweig is a professor and head of the Laboratory of Molecular Immunology at The Rockefeller University and a Howard Hughes Medical Institute investigator. He is a member of both the US National Academy of Medicine and the US National Academy of Sciences.
Thomas Boehm is a German immunologist. He is a Director of the Max Planck Institute for Immunobiology and Epigenetics in Freiburg im Breisgau. He has won a variety of prizes for his research work.